The clinical value of combination of immune checkpoint inhibitors in cancer patients: A meta-analysis of efficacy and safety-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The clinical value of combination of immune checkpoint inhibitors in cancer patients: A meta-analysis of efficacy and safety

Published:2017-08-30 Issue:12 Volume:141 Page:2562-2570
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Wu Yingcheng¹^ORCID,Shi Hui²,Jiang Maorong³,Qiu Mingyan¹,Jia Keren¹,Cao Tianyue¹,Shang Yujuan⁴,Shi Lili⁴,Jiang Kui⁴,Wu Huiqun⁴

Affiliation:

1. Medical School of Nantong University; Jiangsu China

2. Department of Thoracic Surgery; Affiliated Hospital of Nantong University; Nantong Jiangsu China

3. Laboratory Animal Center of Nantong University, Chongchuan District; Nantong Jiangsu China

4. Department of Medical Informatics; Medical School of Nantong University; Jiangsu China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31012/fullpdf

Reference38 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin.,2016

2. FDA approval summary: nivolumab for the treatment of metastatic non-small cell lung cancer with progression on or after platinum-based chemotherapy;Kazandjian;Oncologist.,2016

3. U.S. FDA approval summary: nivolumab for treatment of unresectable or metastatic melanoma following progression on ipilimumab;Hazarika;Clin Cancer Res.,2017

4. CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition;Buchbinder;Am J Clin Oncol.,2016

5. Cancer immunotherapy-immune checkpoint blockade and associated endocrinopathies;Byun;Nat Rev Endocrinol.,2017

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy with Immune Checkpoint Inhibitors for Advanced Colorectal Cancer: A Promising Individualized Treatment Strategy;Frontiers in Bioscience-Landmark;2023-04-06

2. Treatment- and immune-related adverse events of immune checkpoint inhibitors in esophageal or gastroesophageal junction cancer: A network meta-analysis of randomized controlled trials;Frontiers in Oncology;2022-12-08

3. Acute kidney injury in advanced lung cancer patients treated with PD-1 inhibitors: a single center observational study;Journal of Cancer Research and Clinical Oncology;2022-11-03

4. Electrical Stimulation for Immune Modulation in Cancer Treatments;Frontiers in Bioengineering and Biotechnology;2022-01-11

5. The generation of PD-L1 and PD-L2 in cancer cells: From nuclear chromatin reorganization to extracellular presentation;Acta Pharmaceutica Sinica B;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3